These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 24388803)
1. Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents. Li X; Brazauskas R; Wang Z; Al-Seraihy A; Baker KS; Cahn JY; Frangoul HA; Gajewski JL; Hale GA; Hsu JW; Kamble RT; Lazarus HM; Marks DI; Maziarz RT; Savani BN; Shah AJ; Shah N; Sorror ML; Wood WA; Majhail NS Biol Blood Marrow Transplant; 2014 Apr; 20(4):587-92. PubMed ID: 24388803 [TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
3. Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes. Duncan CN; Majhail NS; Brazauskas R; Wang Z; Cahn JY; Frangoul HA; Hayashi RJ; Hsu JW; Kamble RT; Kasow KA; Khera N; Lazarus HM; Loren AW; Marks DI; Maziarz RT; Mehta P; Myers KC; Norkin M; Pidala JA; Porter DL; Reddy V; Saber W; Savani BN; Schouten HC; Steinberg A; Wall DA; Warwick AB; Wood WA; Yu LC; Jacobsohn DA; Sorror ML Biol Blood Marrow Transplant; 2015 Jan; 21(1):151-8. PubMed ID: 25316109 [TBL] [Abstract][Full Text] [Related]
4. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies. Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study. Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339 [TBL] [Abstract][Full Text] [Related]
7. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors. Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174 [TBL] [Abstract][Full Text] [Related]
8. Neurologic complications after allogeneic hematopoietic stem cell transplantation in children: analysis of prognostic factors. Kang JM; Kim YJ; Kim JY; Cho EJ; Lee JH; Lee MH; Lee SH; Sung KW; Koo HH; Yoo KH Biol Blood Marrow Transplant; 2015 Jun; 21(6):1091-8. PubMed ID: 25708217 [TBL] [Abstract][Full Text] [Related]
9. Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM). Socié G; Cahn JY; Carmelo J; Vernant JP; Jouet JP; Ifrah N; Milpied N; Michallet M; Lioure B; Pico JL; Witz F; Molina L; Fischer A; Bardou VJ; Gluckman E; Reiffers J Br J Haematol; 1997 Jun; 97(4):865-70. PubMed ID: 9217190 [TBL] [Abstract][Full Text] [Related]
10. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review. Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924 [TBL] [Abstract][Full Text] [Related]
11. Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation. Inagaki J; Moritake H; Nishikawa T; Hyakuna N; Okada M; Suenobu S; Nagai K; Honda Y; Shimomura M; Fukano R; Noguchi M; Kurauchi K; Tanioka S; Okamura J Biol Blood Marrow Transplant; 2015 Nov; 21(11):1973-80. PubMed ID: 26234723 [TBL] [Abstract][Full Text] [Related]
12. Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation. Law AD; Bhella S; Pasic I; Lam W; Michelis FV; Gerbitz A; Viswabandya A; Kumar R; Lipton JH; Mattsson J; Kim DDH Ann Hematol; 2021 May; 100(5):1311-1319. PubMed ID: 33710366 [TBL] [Abstract][Full Text] [Related]
13. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival. Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907 [TBL] [Abstract][Full Text] [Related]
14. Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning Is Successful in Children with Hematologic Cytopenias of Genetic Origin. Kothari A; Ngwube A; Hayashi R; Murray L; Davis J; Haut P; Loechelt BJ; Shenoy S Biol Blood Marrow Transplant; 2015 Jul; 21(7):1321-5. PubMed ID: 25840334 [TBL] [Abstract][Full Text] [Related]
15. Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies. Naik S; Martinez C; Leung K; Sasa G; Nguyen NY; Wu MF; Gottschalk S; Brenner M; Heslop H; Krance R Biol Blood Marrow Transplant; 2015 Jul; 21(7):1266-72. PubMed ID: 25765555 [TBL] [Abstract][Full Text] [Related]
16. Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease. Bhutani D; Dyson G; Manasa R; Deol A; Ratanatharathorn V; Ayash L; Abidi M; Lum LG; Al-Kadhimi Z; Uberti JP Biol Blood Marrow Transplant; 2015 Jan; 21(1):159-64. PubMed ID: 25445637 [TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027. Kamboj M; Xiao K; Kaltsas A; Huang YT; Sun J; Chung D; Wu S; Sheahan A; Sepkowitz K; Jakubowski AA; Papanicolaou G Biol Blood Marrow Transplant; 2014 Oct; 20(10):1626-33. PubMed ID: 24973628 [TBL] [Abstract][Full Text] [Related]
18. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review. Tauchmanovà L; De Rosa G; Serio B; Fazioli F; Mainolfi C; Lombardi G; Colao A; Salvatore M; Rotoli B; Selleri C Cancer; 2003 May; 97(10):2453-61. PubMed ID: 12733144 [TBL] [Abstract][Full Text] [Related]
19. Corticosteroid dose as a risk factor for avascular necrosis of the bone after hematopoietic cell transplantation. McAvoy S; Baker KS; Mulrooney D; Blaes A; Arora M; Burns LJ; Majhail NS Biol Blood Marrow Transplant; 2010 Sep; 16(9):1231-6. PubMed ID: 20302963 [TBL] [Abstract][Full Text] [Related]
20. Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation. Campbell S; Sun CL; Kurian S; Francisco L; Carter A; Kulkarni S; Parker P; Karanes C; Forman SJ; Bhatia S Cancer; 2009 Sep; 115(18):4127-35. PubMed ID: 19536905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]